We reported previously that the prognosis of EGPA could be improved by IVIG [15] via an increase in either the number of CD4+CD25+ T cells producing IL-10 [61] or the number of FOXP3+ regulatory T cells [62]. The gene discussed is FOXP3; the disease is eosinophilic granulomatosis with polyangiitis.